Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.44 - $4.32 $956,336 - $1.69 Million
-391,941 Reduced 67.08%
192,341 $525,000
Q1 2024

May 15, 2024

BUY
$1.36 - $3.84 $624,492 - $1.76 Million
459,186 Added 367.07%
584,282 $2.03 Million
Q4 2023

Feb 14, 2024

SELL
$1.28 - $1.6 $199,650 - $249,563
-155,977 Reduced 55.49%
125,096 $178,000
Q2 2023

Aug 14, 2023

SELL
$1.31 - $1.79 $303,709 - $414,991
-231,839 Reduced 45.2%
281,073 $441,000
Q1 2023

May 15, 2023

SELL
$1.48 - $2.19 $221,933 - $328,401
-149,955 Reduced 22.62%
512,912 $785,000
Q4 2022

Feb 14, 2023

BUY
$1.25 - $1.94 $577,755 - $896,675
462,204 Added 230.34%
662,867 $1.11 Million
Q3 2022

Nov 14, 2022

SELL
$1.19 - $2.06 $669,886 - $1.16 Million
-562,930 Reduced 73.72%
200,663 $247,000
Q2 2022

Aug 15, 2022

BUY
$1.59 - $2.7 $1.21 Million - $2.06 Million
763,593 New
763,593 $1.28 Million
Q1 2022

May 16, 2022

SELL
$2.02 - $3.92 $456,358 - $885,606
-225,920 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.74 - $6.7 $272,466 - $488,108
72,852 Added 47.59%
225,920 $845,000
Q3 2021

Nov 15, 2021

BUY
$6.05 - $10.41 $307,642 - $529,348
50,850 Added 49.75%
153,068 $960,000
Q2 2021

Aug 16, 2021

SELL
$6.66 - $10.92 $5.37 Million - $8.81 Million
-806,695 Reduced 88.75%
102,218 $1.01 Million
Q1 2021

May 17, 2021

BUY
$4.59 - $18.74 $3.73 Million - $15.2 Million
812,958 Added 847.23%
908,913 $8.49 Million
Q4 2020

Feb 16, 2021

SELL
$3.93 - $5.5 $420,867 - $589,000
-107,091 Reduced 52.74%
95,955 $461,000
Q3 2020

Nov 16, 2020

BUY
$4.01 - $5.56 $417,027 - $578,223
103,997 Added 105.0%
203,046 $814,000
Q2 2020

Aug 14, 2020

BUY
$3.0 - $5.52 $297,147 - $546,750
99,049 New
99,049 $455,000
Q4 2019

Feb 14, 2020

SELL
$2.83 - $4.61 $437,894 - $713,319
-154,733 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$3.83 - $4.72 $513,162 - $632,409
133,985 Added 645.77%
154,733 $608,000
Q2 2019

Aug 15, 2019

SELL
$3.71 - $4.83 $135,990 - $177,043
-36,655 Reduced 63.86%
20,748 $96,000
Q2 2019

Aug 14, 2019

BUY
$3.71 - $4.83 $212,965 - $277,256
57,403 New
57,403 $5.25 Million
Q2 2018

Aug 14, 2018

SELL
$3.22 - $4.43 $1.62 Million - $2.24 Million
-504,525 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$4.05 - $6.46 $155,799 - $248,509
-38,469 Reduced 7.08%
504,525 $2.12 Million
Q4 2017

Feb 14, 2018

BUY
$3.88 - $6.96 $798,705 - $1.43 Million
205,852 Added 61.06%
542,994 $3.19 Million
Q3 2017

Nov 14, 2017

BUY
$2.91 - $4.71 $981,083 - $1.59 Million
337,142
337,142 $1.45 Million

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $509M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.